News and Events Recent News Dec 8, 2022 Arrowhead Announces First Patient Enrolled in Phase 1 Trial Evaluating HZN-457 for the Treatment of Gout Nov 28, 2022 Arrowhead Pharmaceuticals Reports Fiscal 2022 Year End Results Nov 21, 2022 Arrowhead Pharmaceuticals to Participate in Upcoming Investor Conferences View More » Recent Events Dec 1, 2022 Evercore ISI 5th Annual HealthCONx Conference Nov 30, 2022 Piper Sandler 34th Annual Healthcare Conference Nov 28, 2022 Arrowhead Pharmaceuticals Fiscal 2022 Year End Results View More »
Dec 8, 2022 Arrowhead Announces First Patient Enrolled in Phase 1 Trial Evaluating HZN-457 for the Treatment of Gout